Fig. 16 | Scientific Reports

Fig. 16

From: Cilazapril and benazepril mitigate neurodegeneration and α-synuclein accumulation in a cellular model of parkinson’s disease

Fig. 16The alternative text for this image may have been generated using AI.

Real-time PCR analysis of D1 and D2 dopamine receptor gene expression. (a) Cilazapril-D1: Effect of cilazapril on D1 receptor expression. (b) Benazepril-D1: Effect of benazepril on D1 receptor expression. The effects of different doses (0.04 µM–5.12 µM) of cilazapril and benazepril on D1 and D2 dopamine receptor gene expression were evaluated.

Back to article page